TrialThe oncologist2019

Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer.

Hiroto Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.